Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,165.08
(
0.80%
)
US TECH 100
26,538.40
(
1.85%
)
Dow Jones
49,247.66
(
-0.13%
)
Brent Oil
100.66
(
0.00%
)
Bitcoin
78,240.04
(
0.80%
)
News Focus
News Focus
Post# of 97241
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

10bags

Send PM Follow Ignore
Followers 364
Posts 17907
Boards Moderated 3
Alias Born 04/02/2009

10bags

Re: $heff post# 22514

Friday, 01/22/2010 10:33:22 AM

Friday, January 22, 2010 10:33:22 AM

Post# of 97241
PARD-->
Picoplatin for the Treatment of Colorectal Cancer

Present additional data from the Company's Phase 2 trial evaluating picoplatin as a neuropathy-sparing agent compared to oxaliplatin in the first-line treatment of patients with metastatic colorectal cancer (CRC) on Sunday, January 24, 2010 at the ASCO 2010 Gastrointestinal Cancers Symposium in Orlando, Fla. This randomized,

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today